The Impact of a Locally Tailored Evidence-based Chinese Smartphone Application in Management of Type 1 Diabetes Mellitus Aged 6-18 Years in Hong Kong - a Randomized Controlled Trial
This clinical trial, sponsored by the Chinese University of Hong Kong, addresses a significant gap in diabetes management for pediatric patients in Hong Kong, where no Chinese-language smartphone applications currently exist. The trial aims to evaluate the effectiveness of a tailored application that incorporates local clinical practices and cultural dietary considerations. Given the high smartphone penetration among the youth in Hong Kong, the potential market for such an application is substantial. If successful, this initiative could lead to a competitive advantage in the digital health space, particularly for companies focusing on diabetes management solutions. The trial's outcomes could also attract interest from investors and stakeholders in the digital therapeutics sector, emphasizing the importance of culturally relevant healthcare solutions.
Indication: Type1 Diabetes Mellitus
Modality: medical device
Target: The intervention targets the management of Type 1 Diabetes Mellitus (T1DM) in pediatric patients aged 6-18 years through a locally tailored smartphone application designed to improve diabetes control and psychological wellbeing.
Sponsor: Chinese University of Hong Kong
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 18, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: The intervention targets the management of Type 1 Diabetes Mellitus (T1DM) in pediatric patients aged 6-18 years through a locally tailored smartphone application designed to improve diabetes control and psychological wellbeing.
View original source fields
Condition raw: Type1 Diabetes Mellitus
Condition normalized: Type1 Diabetes Mellitus
Modality raw: medical device
Modality normalized: medical device
Target raw: The intervention targets the management of Type 1 Diabetes Mellitus (T1DM) in pediatric patients aged 6-18 years through a locally tailored smartphone application designed to improve diabetes control and psychological wellbeing.
Target normalized: The intervention targets the management of Type 1 Diabetes Mellitus (T1DM) in pediatric patients aged 6-18 years through a locally tailored smartphone application designed to improve diabetes control and psychological wellbeing.